{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:04:59Z","timestamp":1790762699317,"version":"4.1.0"},"reference-count":127,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"abstract":"<jats:p>Cancer remains a major global health challenge, and growing evidence indicates that the gut microbiota plays an important role in cancer initiation, progression, metastasis, and response to treatment through complex interactions with host signaling, metabolism, and immunity. This comprehensive narrative review discusses the molecular mechanisms underlying gut microbiota\u2013cancer crosstalk, with particular emphasis on dysbiosis, microbial metabolites, immune modulation, and microbiota-regulated oncogenic pathways, including TLR\/NF-\u03baB, Wnt\/\u03b2-catenin, JAK\/STAT, PI3K\/Akt\/mTOR, and Hippo-YAP signaling. The review also examines emerging molecular targets, including microbial extracellular vesicles, bacterial small RNAs, ferroptosis-related mechanisms, and microbiota\u2013mitochondria interactions. In addition, current microbiota-targeted therapeutic strategies, such as fecal microbiota transplantation, engineered bacterial therapeutics, CRISPR-based microbiome engineering, and microbiome-informed approaches to precision oncology are discussed. Relevant peer-reviewed literature published primarily within the recent 5-year period was considered from major scientific databases and publisher platforms, including PubMed, Scopus, Web of Science, Springer, Elsevier, and MDPI. Overall, the available evidence suggests that gut microbiota represents an important component of the tumor ecosystem and may provide promising biomarkers and therapeutic targets. Integration of microbiome research with multi-omics and artificial intelligence may further support the development of personalized cancer treatment.<\/jats:p>","DOI":"10.3389\/fmolb.2026.1924197","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:36:02Z","timestamp":1790760962000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Gut microbiota\u2013cancer crosstalk: emerging molecular targets for personalized cancer treatment- a comprehensive review"],"prefix":"10.3389","volume":"13","author":[{"given":"Pooja","family":"Negi","sequence":"first","affiliation":[{"name":"College of Pharmacy, Graphic Era Hill University, Bhimtal Campus","place":["Bhimtal, Uttarakhand, India"]},{"name":"Centre for Promotion of Research, Graphic Era (Deemed to be) University","place":["Dehradun, Uttarakhand, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpita","family":"Upreti","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Science, Amrapali University","place":["Haldwani, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeti","family":"Budhlakoti","sequence":"additional","affiliation":[{"name":"Vasudev College of Pharmacy","place":["Haldwani, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit Kumar","family":"Sen","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Samrat Prithviraj Chauhan College of Pharmacy","place":["Kashipur, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitali","family":"Danu","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Science, Amrapali University","place":["Haldwani, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumit","family":"Tewari","sequence":"additional","affiliation":[{"name":"Vasudev College of Pharmacy","place":["Haldwani, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirmal","family":"Joshi","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Science, Amrapali University","place":["Haldwani, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Chandra Joshi","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard","place":["New Delhi, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.3390\/microorganisms10102048","article-title":"Gut microbiota-derived short-chain fatty acids: impact on cancer treatment response and toxicities","volume":"10","author":"Al-Qadami","year":"2022","journal-title":"Microorganisms"},{"key":"B2","doi-asserted-by":"publisher","first-page":"3946","DOI":"10.3390\/cancers17243946","article-title":"From microbiota to cancer: role of extracellular vesicles in gut-lung axis","volume":"17","author":"Albano","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"944","DOI":"10.3390\/bioengineering12090944","article-title":"Smart microbiomes: how AI is revolutionizing personalized medicine","volume":"12","author":"Alexandrescu","year":"2025","journal-title":"Bioeng. (Basel)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1007\/s12602-025-10573-8","article-title":"Harnessing the microbiome: CRISPR-based gene editing and antimicrobial peptides in combating antibiotic resistance and cancer","volume":"17","author":"Amen","year":"2025","journal-title":"Probiotics Antimicrob. Proteins"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e184","DOI":"10.52225\/narra.v3i2.184","article-title":"Application of CRISPR-Cas9 genome editing technology in various fields: a review","volume":"3","author":"Ansori","year":"2023","journal-title":"Narra J."},{"key":"B6","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1126\/science.abb5920","article-title":"Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients","volume":"371","author":"Baruch","year":"2021","journal-title":"Science"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.3390\/biom15111546","article-title":"Gut microbiota and ferroptosis in colorectal cancer: a comprehensive review of mechanisms and therapeutic strategies to overcome immune checkpoint resistance","volume":"15","author":"Cai","year":"2025","journal-title":"Biomolecules"},{"key":"B8","doi-asserted-by":"publisher","first-page":"107321","DOI":"10.1016\/j.phrs.2024.107321","article-title":"Host-gut microbiota metabolic interactions and their role in precision diagnosis and treatment of gastrointestinal cancers","volume":"207","author":"Cao","year":"2024","journal-title":"Pharmacol. Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3390\/metabo15040220","article-title":"Trimethylamine-N-Oxide (TMAO) as a rising-star metabolite: implications for human health","volume":"15","author":"Caradonna","year":"2025","journal-title":"Metabolites"},{"key":"B10","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2478\/aiht-2020-71-3366","article-title":"Ferroptosis: regulated cell death","volume":"71","author":"\u010cepelak","year":"2020","journal-title":"Arh. Hig. Rada Toksikol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1545334","DOI":"10.3389\/fmicb.2025.1545334","article-title":"Resynthesis of synthetic biology techniques: combining engineered bacteria with other antitumour therapies","volume":"16","author":"Chang","year":"2025","journal-title":"Front. Microbiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"100878","DOI":"10.1016\/j.neo.2023.100878","article-title":"The influence of the microbiome on the innate immune microenvironment of solid tumors","volume":"37","author":"Charles","year":"2023","journal-title":"Neoplasia"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e30527","DOI":"10.1002\/jcb.30527","article-title":"Helicobacter pylori CagA protein induces gastric cancer stem cell-like properties through the Akt\/FOXO3a axis","volume":"125","author":"Chen","year":"2024","journal-title":"J. Cell Biochem."},{"key":"B14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12929-025-01208-9","article-title":"Microbiome modulation of tumorigenesis and immune responses","volume":"33","author":"Chen","year":"2026","journal-title":"J. Biomed. Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41392-025-02264-1","article-title":"Pattern recognition receptors: function, regulation and therapeutic potential","volume":"10","author":"Chen R.","year":"2025","journal-title":"Signal Transduct. Target Ther."},{"key":"B16","doi-asserted-by":"publisher","first-page":"657","DOI":"10.21147\/j.issn.1000-9604.2025.05.01","article-title":"Gut microbiota and acute graft-versus-host disease","volume":"37","author":"Chen Z.","year":"2025","journal-title":"Chin. J. Cancer Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1136\/gutjnl-2020-321153","article-title":"The role of gut microbiota in cancer treatment: friend or foe?","volume":"69","author":"Cheng","year":"2020","journal-title":"Gut"},{"key":"B18","doi-asserted-by":"publisher","first-page":"G554","DOI":"10.1152\/ajpgi.00223.2019","article-title":"Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy","volume":"318","author":"Chiang","year":"2020","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"101143","DOI":"10.1016\/j.mam.2022.101143","article-title":"The subversion of toll-like receptor signaling by bacterial and viral proteases during the development of infectious diseases","volume":"88","author":"Ciaston","year":"2022","journal-title":"Mol. Asp. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1434799","DOI":"10.3389\/fmedt.2024.1434799","article-title":"Advanced computational tools, artificial intelligence and machine-learning approaches in gut microbiota and biomarker identification","volume":"6","author":"Dakal","year":"2024","journal-title":"Front. Med. Technol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"104312","DOI":"10.1016\/j.critrevonc.2024.104312","article-title":"Involvement of CircRNAs in regulating the \u201cnew generation of cancer hallmarks\u201d: a special depiction on hepatocellular carcinoma","volume":"196","author":"Dawoud","year":"2024","journal-title":"Crit. Rev. Oncology\/Hematology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e70042","DOI":"10.1002\/cph4.70042","article-title":"Crosstalk between microbiome and ferroptosis in diseases: from mechanism to therapy","volume":"15","author":"Ding","year":"2025","journal-title":"Compr. Physiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2185028","DOI":"10.1080\/19490976.2023.2185028","article-title":"Intestinal bacteria and colorectal cancer: etiology and treatment","volume":"15","author":"Dougherty","year":"2023","journal-title":"Gut Microbes"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.3390\/cancers18091453","article-title":"Artificial intelligence-guided personalized gut microbiome modulation for persistent secondary gastrointestinal symptoms in oncology patients: clinical efficacy and biological correlates from a prospective validation study","volume":"18","author":"Dragomir","year":"2026","journal-title":"Cancers (Basel)"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1509117","DOI":"10.3389\/fmicb.2024.1509117","article-title":"Advances in multi-omics integrated analysis methods based on the gut microbiome and their applications","volume":"15","author":"Duan","year":"2024","journal-title":"Front. Microbiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1675677","DOI":"10.3389\/fimmu.2025.1675677","article-title":"Microbial metabolites and their influence on the tumor microenvironment","volume":"16","author":"Duan H.","year":"2025","journal-title":"Front. Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13045-024-01654-2","article-title":"Helicobacter pylori and gastric cancer: mechanisms and new perspectives","volume":"18","author":"Duan Y.","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1559480","DOI":"10.3389\/fimmu.2025.1559480","article-title":"Microbiota as diagnostic biomarkers: advancing early cancer detection and personalized therapeutic approaches through microbiome profiling","volume":"16","author":"Eslami","year":"2025","journal-title":"Front. Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"104019","DOI":"10.1016\/j.micpath.2020.104019","article-title":"The oncogenic roles of bacterial infections in development of cancer","volume":"141","author":"Eyvazi","year":"2020","journal-title":"Microb. Pathog."},{"key":"B30","doi-asserted-by":"publisher","first-page":"817844","DOI":"10.3389\/fmicb.2022.817844","article-title":"Biogenesis and biological functions of extracellular vesicles in cellular and organismal communication with microbes","volume":"13","author":"Fang","year":"2022","journal-title":"Front. Microbiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.3390\/biomedicines12122776","article-title":"Microbiota and cytokine modulation: innovations in enhancing anticancer immunity and personalized cancer therapies","volume":"12","author":"Farhadi Rad","year":"2024","journal-title":"Biomedicines"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1377012","DOI":"10.3389\/fcimb.2024.1377012","article-title":"Current progresses and challenges for microbiome research in human health: a perspective","volume":"14","author":"Filardo","year":"2024","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/ncrna11040056","article-title":"circRNA\/miRNA networks regulate KLF4 in tumor development","volume":"11","author":"Frazzi","year":"2025","journal-title":"Noncoding RNA"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.3390\/biomedicines9081016","article-title":"Targeting STAT3 signaling pathway in colorectal cancer","volume":"9","author":"Gargalionis","year":"2021","journal-title":"Biomedicines"},{"key":"B35","doi-asserted-by":"publisher","first-page":"104211","DOI":"10.1016\/j.exphem.2024.104211","article-title":"Gut microbial dysbiosis in the pathogenesis of leukemia: an immune-based perspective","volume":"133","author":"Goswami","year":"2024","journal-title":"Exp. Hematol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1089\/apb.2024.0002","article-title":"A review of clinical trials involving genetically modified bacteria, bacteriophages and their associated risk assessments","volume":"29","author":"Gulig","year":"2024","journal-title":"Appl. Biosaf."},{"key":"B37","doi-asserted-by":"publisher","first-page":"108557","DOI":"10.1016\/j.cclet.2023.108557","article-title":"Harnessing bacteria for tumor therapy: current advances and challenges","volume":"35","author":"Guo","year":"2024","journal-title":"Chin. Chem. Lett."},{"key":"B38","doi-asserted-by":"publisher","first-page":"102399","DOI":"10.1016\/j.xcrm.2025.102399","article-title":"In situ extended immune activation instantly after tumor resection by oncolytic virus controls postoperative tumor recurrence","volume":"6","author":"Guo","year":"2025","journal-title":"Cell Rep. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1016\/j.chom.2024.11.006","article-title":"Campylobacter jejuni-derived cytolethal distending toxin promotes colorectal cancer metastasis","volume":"32","author":"He","year":"2024","journal-title":"Cell Host Microbe"},{"key":"B40","doi-asserted-by":"publisher","first-page":"108703","DOI":"10.1016\/j.compbiolchem.2025.108703","article-title":"Microbiome-transcriptome-histology triad enhances survival risk stratification in multiple cancers","volume":"120","author":"He","year":"2026","journal-title":"Comput. Biol. Chem."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.3390\/cells13231987","article-title":"Using new technologies to analyze gut microbiota and predict cancer risk","volume":"13","author":"Hemmati","year":"2024","journal-title":"Cells"},{"key":"B42","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3389\/fmolb.2019.00160","article-title":"Extracellular matrix in the tumor microenvironment and its impact on cancer therapy","volume":"6","author":"Henke","year":"2019","journal-title":"Front. Mol. Biosci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s10238-025-01965-9","article-title":"AI-driven multi-omics integration in precision oncology: bridging the data deluge to clinical decisions","volume":"26","author":"Hsu","year":"2025","journal-title":"Clin. Exp. Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1649438","DOI":"10.3389\/fimmu.2025.1649438","article-title":"Communication between gut microbiota-derived metabolites and the tumor microenvironment","volume":"16","author":"Hu","year":"2025","journal-title":"Front. Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"100829","DOI":"10.1016\/j.neo.2022.100829","article-title":"Microbiota-driven mechanisms at different stages of cancer development","volume":"32","author":"Ivleva","year":"2022","journal-title":"Neoplasia"},{"key":"B46","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3390\/toxins17060305","article-title":"Biological mechanisms of enterotoxigenic Bacteroides fragilis toxin: linking inflammation, colorectal cancer, and clinical implications","volume":"17","author":"Jasemi","year":"2025","journal-title":"Toxins (Basel)"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1097\/cm9.0000000000003617","article-title":"Intestinal dysbiosis and colorectal cancer","volume":"138","author":"Kang","year":"2025","journal-title":"Chin. Med. J. Engl."},{"key":"B48","doi-asserted-by":"publisher","first-page":"100804","DOI":"10.1016\/j.patter.2023.100804","article-title":"Leakage and the reproducibility crisis in machine-learning-based science","volume":"4","author":"Kapoor","year":"2023","journal-title":"Patterns"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.3390\/microorganisms13122687","article-title":"Role of probiotics in enhancing immune function and improving the effectiveness of treatments for pancreatic cancer","volume":"13","author":"Kaur","year":"2025","journal-title":"Microorganisms"},{"key":"B50","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s00262-025-04118-9","article-title":"Gut modulation to regulate NF-\u03baB in colorectal and gastric cancer therapy and inflammation","volume":"74","author":"Kearns","year":"2025","journal-title":"Cancer Immunol. Immunother."},{"key":"B51","doi-asserted-by":"publisher","first-page":"107585","DOI":"10.1016\/j.ijantimicag.2025.107585","article-title":"Exploring the therapeutic potential of bacteriophage-mediated modulation of gut microbiota towards colorectal cancer","volume":"66","author":"Kenneth","year":"2025","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B52","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3390\/diseases9040079","article-title":"Exploring the inflammatory pathogenesis of colorectal cancer","volume":"9","author":"Khalyfa","year":"2021","journal-title":"Diseases"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1705116","DOI":"10.3389\/fmicb.2026.1705116","article-title":"STROBE-Causal machine learning for the human microbiome: systematic review on methodological innovations and validation frameworks","volume":"17","author":"Khelfaoui","year":"2026","journal-title":"Front. Microbiol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"6701","DOI":"10.3390\/ijms24076701","article-title":"The role of toll-like receptors (TLRs) and their related signaling pathways in viral infection and inflammation","volume":"24","author":"Kircheis","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B55","doi-asserted-by":"publisher","first-page":"240","DOI":"10.37349\/etat.2023.00132","article-title":"Gut microbiota, an emergent target to shape the efficiency of cancer therapy","volume":"4","author":"Kouidhi","year":"2023","journal-title":"Explor Target Antitumor Ther."},{"key":"B56","doi-asserted-by":"publisher","first-page":"e1006440","DOI":"10.1371\/journal.ppat.1006440","article-title":"Streptococcus gallolyticus subsp. gallolyticus promotes colorectal tumor development","volume":"13","author":"Kumar","year":"2017","journal-title":"PLoS Pathog."},{"key":"B57","doi-asserted-by":"publisher","first-page":"e1404","DOI":"10.1002\/cti2.1404","article-title":"Inflammasome activation: from molecular mechanisms to autoinflammation","volume":"11","author":"Lara-Reyna","year":"2022","journal-title":"Clin. Transl. Immunol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1089\/sur.2023.014","article-title":"Defining the microbiome components (Bacteria, viruses, fungi) and microbiome geodiversity","volume":"24","author":"Leonard","year":"2023","journal-title":"Surg. Infect. (Larchmt)"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1582166","DOI":"10.3389\/fimmu.2025.1582166","article-title":"Crosstalk between metabolic reprogramming and microbiota: implications for cancer progression and novel therapeutic opportunities","volume":"16","author":"Li","year":"","journal-title":"Front. Immunol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"2464225","DOI":"10.1080\/19490976.2025.2464225","article-title":"Uncovering de novo polyamine biosynthesis in the gut microbiome and its alteration in inflammatory bowel disease","volume":"17","author":"Li","year":"","journal-title":"Gut Microbes"},{"key":"B61","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jare.2023.11.027","article-title":"The role of gut microbiota and metabolites in cancer chemotherapy","volume":"64","author":"Li","year":"2024","journal-title":"J. Adv. Res."},{"key":"B62","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13045-024-01541-w","article-title":"Critical role of the gut microbiota in immune responses and cancer immunotherapy","volume":"17","author":"Li Z.","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"102601","DOI":"10.1016\/j.redox.2023.102601","article-title":"Implications of hydrogen sulfide in colorectal cancer: mechanistic insights and diagnostic and therapeutic strategies","volume":"59","author":"Lin","year":"2023","journal-title":"Redox Biol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.7150\/thno.91700","article-title":"Role of the gut microbiota in tumorigenesis and treatment","volume":"14","author":"Liu","year":"2024","journal-title":"Theranostics"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1556827","DOI":"10.3389\/fmicb.2025.1556827","article-title":"Fecal microbiota transplantation: application scenarios, efficacy prediction, and factors impacting donor-recipient interplay","volume":"16","author":"Liu","year":"2025","journal-title":"Front. Microbiol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"13465","DOI":"10.2147\/jir.S540163","article-title":"The role of butyric acid and microorganisms in chronic inflammatory diseases and microbiome-based therapeutics","volume":"18","author":"Liu","year":"2025","journal-title":"J. Inflamm. Res."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1080\/19490976.2020.1758008","article-title":"Host-microbiome interactions: the aryl hydrocarbon receptor as a critical node in tryptophan metabolites to brain signaling","volume":"11","author":"Ma","year":"2020","journal-title":"Gut Microbes"},{"key":"B68","doi-asserted-by":"publisher","first-page":"688","DOI":"10.3390\/biom15050688","article-title":"The effect of microbiome-derived metabolites in inflammation-related cancer prevention and treatment","volume":"15","author":"Mafe","year":"2025","journal-title":"Biomolecules"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jitc-2020-001383","article-title":"Microbiome-derived metabolome as a potential predictor of response to cancer immunotherapy","volume":"8","author":"Malczewski","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"B70","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/s41423-025-01310-w","article-title":"NF-\u03baB in inflammation and cancer","volume":"22","author":"Mao","year":"2025","journal-title":"Cell Mol. Immunol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"11706","DOI":"10.3390\/ijms231911706","article-title":"The role of cyclomodulins and some microbial metabolites in bacterial microecology and macroorganism carcinogenesis","volume":"23","author":"Markelova","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B72","doi-asserted-by":"publisher","first-page":"11868","DOI":"10.3390\/ijms252211868","article-title":"Impact on human health of Salmonella spp. and their lipopolysaccharides: possible therapeutic role and asymptomatic presence consequences","volume":"25","author":"Miko\u0142ajczyk","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B73","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12943-025-02564-8","article-title":"Gut microbiota drives cancer evolution and therapy resistance","volume":"25","author":"Min","year":"2026","journal-title":"Mol. Cancer"},{"key":"B74","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/cac2.12518","article-title":"Engineered extracellular vesicles: a new approach for targeted therapy of tumors and overcoming drug resistance","volume":"44","author":"Ming-Kun","year":"2024","journal-title":"Cancer Commun. (Lond)"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.7150\/thno.125301","article-title":"Advances in the engineering of living probiotics for cancer immunotherapy","volume":"16","author":"Muhammad","year":"2026","journal-title":"Theranostics"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1403089","DOI":"10.3389\/fonc.2024.1403089","article-title":"Porphyromonas gingivalis, a bridge between oral health and immune evasion in gastric cancer","volume":"14","author":"Mu\u00f1oz-Medel","year":"2024","journal-title":"Front. Oncol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3390\/cells14070488","article-title":"The role of inflammation in cancer: mechanisms of tumor initiation, progression, and metastasis","volume":"14","author":"Nishida","year":"2025","journal-title":"Cells"},{"key":"B78","doi-asserted-by":"publisher","first-page":"866","DOI":"10.3390\/cancers15030866","article-title":"Gut microbiota in colorectal cancer: biological role and therapeutic opportunities","volume":"15","author":"Pandey","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B79","doi-asserted-by":"publisher","first-page":"A401","DOI":"10.1136\/jitc-2020-SITC2020.0376","article-title":"376 A phase I\/II study of live biotherapeutic MRx0518 in combination with pembrolizumab in patients refractory to immune checkpoint inhibitors","volume":"8","author":"Pant","year":"2020","journal-title":"J. Immunother Cancer"},{"key":"B80","doi-asserted-by":"publisher","first-page":"114004","DOI":"10.1016\/j.jconrel.2025.114004","article-title":"Optimized bacterial delivery approaches for precision immunotherapy in breast cancer models","volume":"385","author":"Park","year":"2025","journal-title":"J. Control. Release"},{"key":"B81","doi-asserted-by":"publisher","first-page":"e71463","DOI":"10.1002\/cam4.71463","article-title":"Cancer risk prediction using machine learning for supporting early cancer diagnosis in symptomatic patients: a systematic review of model types","volume":"14","author":"Pennisi","year":"2025","journal-title":"Cancer Med."},{"key":"B82","doi-asserted-by":"publisher","first-page":"fuac017","DOI":"10.1093\/femsre\/fuac017","article-title":"An overview of gene regulation in bacteria by small RNAs derived from mRNA 3' ends","volume":"46","author":"Ponath","year":"2022","journal-title":"FEMS Microbiol. Rev."},{"key":"B83","doi-asserted-by":"publisher","first-page":"e70455","DOI":"10.1002\/cnr2.70455","article-title":"Exploring fecal microbiota transplantation: potential benefits, associated risks, and challenges in cancer treatment","volume":"9","author":"Ramesh","year":"2026","journal-title":"Cancer Rep. Hob."},{"key":"B84","doi-asserted-by":"publisher","first-page":"e2503045","DOI":"10.4014\/jmb.2503.03045","article-title":"Indole propionic acid regulates gut immunity: mechanisms of metabolite-driven immunomodulation and barrier integrity","volume":"35","author":"Ren","year":"2025","journal-title":"J. Microbiol. Biotechnol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/microorganisms7010014","article-title":"What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases","volume":"7","author":"Rinninella","year":"2019","journal-title":"Microorganisms"},{"key":"B86","doi-asserted-by":"publisher","first-page":"934695","DOI":"10.3389\/fimmu.2022.934695","article-title":"Akkermansia muciniphila and gut immune system: a good friendship that attenuates inflammatory bowel disease, obesity, and diabetes","volume":"13","author":"Rodrigues","year":"2022","journal-title":"Front. Immunol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.3390\/microorganisms12061111","article-title":"Contribution of pks+ Escherichia coli (E. coli) to Colon Carcinogenesis","volume":"12","author":"Sadeghi","year":"2024","journal-title":"Microorganisms"},{"key":"B88","doi-asserted-by":"publisher","first-page":"100139","DOI":"10.1016\/j.medmic.2025.100139","article-title":"Short-chain fatty acids (SCFAs) in gut health: implications for drug metabolism and therapeutics","volume":"25","author":"Sankarganesh","year":"2025","journal-title":"Med. Microecology"},{"key":"B89","doi-asserted-by":"publisher","first-page":"2435391","DOI":"10.1080\/21505594.2024.2435391","article-title":"Peptostreptococcus anaerobius enhances dextran sulfate sodium-induced colitis by promoting nf-\u03baB-NLRP3-Dependent macrophage pyroptosis","volume":"15","author":"Shen","year":"2024","journal-title":"Virulence"},{"key":"B90","doi-asserted-by":"publisher","first-page":"e70168","DOI":"10.1002\/mco2.70168","article-title":"Gut microbiota dysbiosis: pathogenesis, diseases, prevention, and therapy","volume":"6","author":"Shen","year":"2025","journal-title":"MedComm (2020)"},{"key":"B91","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3390\/biomedicines14020261","article-title":"Artificial intelligence drives advances in multi-omics analysis and precision medicine for sepsis","volume":"14","author":"Shen","year":"2026","journal-title":"Biomedicines"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1782712","DOI":"10.3389\/fcimb.2026.1782712","article-title":"The role and significance of the PI3K\/Akt-mTOR signaling pathway in infectious diseases","volume":"16","author":"Sheng","year":"2026","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"e061674","DOI":"10.1136\/bmjopen-2022-061674","article-title":"Artificial intelligence-derived gut microbiome as a predictive biomarker for therapeutic response to immunotherapy in lung cancer: protocol for a multicentre, prospective, observational study","volume":"12","author":"Shoji","year":"2022","journal-title":"BMJ Open"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1038\/s41396-023-01483-0","article-title":"Potential effects of gut microbiota on host cancers: focus on immunity, DNA damage, cellular pathways, and anticancer therapy","volume":"17","author":"Sun","year":"2023","journal-title":"Isme J."},{"key":"B95","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.7150\/ijms.112724","article-title":"Overcoming the delivery challenges in CRISPR\/Cas9 gene editing for effective cancer treatment: a review of delivery systems","volume":"22","author":"Tang","year":"2025","journal-title":"Int. J. Med. Sci."},{"key":"B96","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s41586-019-0878-z","article-title":"A defined commensal consortium elicits CD8 T cells and anti-cancer immunity","volume":"565","author":"Tanoue","year":"2019","journal-title":"Nature"},{"key":"B97","doi-asserted-by":"publisher","first-page":"4131","DOI":"10.3390\/ijms24044131","article-title":"Spermidine-eugenol supplement preserved inflammation-challenged intestinal cells by stimulating autophagy","volume":"24","author":"Truzzi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B98","doi-asserted-by":"publisher","first-page":"885","DOI":"10.3390\/ijms27020885","article-title":"Prostate cancer, JAK\/STAT3 dysregulation, and flavonoids: is there a possible link?","volume":"27","author":"Uivarosi","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"B99","doi-asserted-by":"publisher","first-page":"5845","DOI":"10.2147\/jir.S432747","article-title":"Indole-3-Aldehyde reduces inflammatory responses and restores intestinal epithelial barrier function partially via aryl hydrocarbon receptor (AhR) in experimental colitis models","volume":"16","author":"Wang","year":"2023","journal-title":"J. Inflamm. Res."},{"key":"B100","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.scib.2025.01.029","article-title":"Fecal microbiota transplantation: transitioning from chaos and controversial realm to scientific precision era","volume":"70","author":"Wang","year":"2025","journal-title":"Sci. Bull."},{"key":"B101","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13045-025-01766-3","article-title":"Engineering bacteria for enhanced tumor therapy: from surface modification to synthetic genetic circuits","volume":"19","author":"Wang","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"919424","DOI":"10.3389\/fmicb.2022.919424","article-title":"Mitochondrial function and microbial metabolites as central regulators of intestinal immune responses and cancer","volume":"13","author":"Weber-Stiehl","year":"2022","journal-title":"Front. Microbiol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"103025","DOI":"10.1016\/j.ctrv.2025.103025","article-title":"Fecal microbiota transplantation to enhance cancer treatment outcomes across different cancer types: a systematic literature review","volume":"140","author":"Wekking","year":"2025","journal-title":"Cancer Treat. Rev."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1703964","DOI":"10.3389\/fimmu.2025.1703964","article-title":"Harnessing the gut microbiome to modulate ferroptosis: a metabolic strategy for the treatment of digestive tract cancers","volume":"16","author":"Wen","year":"2025","journal-title":"Front. Immunol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.tranon.2019.03.003","article-title":"Fusobacterium nucleatum contributes to the carcinogenesis of colorectal cancer by inducing inflammation and suppressing host immunity","volume":"12","author":"Wu","year":"2019","journal-title":"Transl. Oncol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"5350","DOI":"10.3390\/cancers14215350","article-title":"The role of Fusobacterium nucleatum in colorectal cancer cell proliferation and migration","volume":"14","author":"Wu","year":"2022","journal-title":"Cancers"},{"key":"B107","doi-asserted-by":"publisher","first-page":"116410","DOI":"10.1016\/j.biopha.2024.116410","article-title":"Gut microbiome-metabolites axis: a friend or foe to colorectal cancer progression","volume":"173","author":"Wu","year":"2024","journal-title":"Biomed. and Pharmacother."},{"key":"B108","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13045-024-01640-8","article-title":"Global burden of cancer and associated risk factors in 204 countries and territories, 1980-2021: a systematic analysis for the GBD 2021","volume":"17","author":"Wu","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"1410928","DOI":"10.3389\/fimmu.2024.1410928","article-title":"The role of the gut microbiota in tumor, immunity, and immunotherapy","volume":"15","author":"Xie","year":"2024","journal-title":"Front. Immunol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.3390\/foods11182863","article-title":"Health benefits and side effects of short-chain fatty acids","volume":"11","author":"Xiong","year":"2022","journal-title":"Foods"},{"key":"B111","doi-asserted-by":"publisher","first-page":"101992","DOI":"10.1016\/j.mcp.2024.101992","article-title":"Insight into the potential of algorithms using AI technology as in vitro diagnostics utilizing microbial extracellular vesicles","volume":"78","author":"Yang","year":"2024","journal-title":"Mol. Cell. Probes"},{"key":"B112","doi-asserted-by":"publisher","first-page":"15347354221114100","DOI":"10.1177\/15347354221114100","article-title":"Research on gut microbiota-derived secondary bile acids in cancer progression","volume":"21","author":"Yang","year":"2022","journal-title":"Integr. Cancer Ther."},{"key":"B113","doi-asserted-by":"publisher","first-page":"103","DOI":"10.12793\/tcp.2018.26.3.103","article-title":"Microbe-derived extracellular vesicles as a smart drug delivery system","volume":"26","author":"Yang","year":"2018","journal-title":"Transl. Clin. Pharmacol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"e2412001","DOI":"10.4014\/jmb.2412.12001","article-title":"Advancing gut microbiome research: the shift from metagenomics to multi-omics and future perspectives","volume":"35","author":"Yang","year":"2025","journal-title":"J. Microbiol. Biotechnol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1111\/1751-7915.13523","article-title":"Bioengineered Escherichia coli nissle 1917 for tumour-targeting therapy","volume":"13","author":"Yu","year":"2020","journal-title":"Microb. Biotechnol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.7150\/ijbs.91771","article-title":"Influence of microbiota on tumor immunotherapy","volume":"20","author":"Yu","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"B117","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.2147\/itt.S569016","article-title":"The role of intestinal microbiota and immune system interactions in autoimmune diseases","volume":"14","author":"Yurtseven","year":"2025","journal-title":"Immunotargets Ther."},{"key":"B118","doi-asserted-by":"publisher","first-page":"1428242","DOI":"10.3389\/fphar.2024.1428242","article-title":"The interplay between mitochondria, the gut microbiome and metabolites and their therapeutic potential in primary mitochondrial disease","volume":"15","author":"Zachos","year":"2024","journal-title":"Front. Pharmacol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s12672-025-02198-8","article-title":"Advancements and limitations in traditional anti-cancer therapies: a comprehensive review of surgery, chemotherapy, radiation therapy, and hormonal therapy","volume":"16","author":"Zafar","year":"2025","journal-title":"Discov. Oncol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/mco2.104","article-title":"NF-\u03baB signaling in inflammation and cancer","volume":"2","author":"Zhang","year":"2021","journal-title":"MedComm (2020)"},{"key":"B121","doi-asserted-by":"publisher","first-page":"1545952","DOI":"10.3389\/fonc.2025.1545952","article-title":"Hippo\/YAP signaling pathway in colorectal cancer: regulatory mechanisms and potential drug exploration","volume":"15","author":"Zhang","year":"2025","journal-title":"Front. Oncol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s43556-025-00248-9","article-title":"Tumor microbiome: roles in tumor initiation, progression, and therapy","volume":"6","author":"Zhang","year":"2025","journal-title":"Mol. Biomed."},{"key":"B123","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12943-022-01616-7","article-title":"Wnt signaling in colorectal cancer: pathogenic role and therapeutic target","volume":"21","author":"Zhao","year":"2022","journal-title":"Mol. Cancer"},{"key":"B124","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41392-023-01406-7","article-title":"Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"key":"B125","doi-asserted-by":"publisher","first-page":"113926","DOI":"10.1016\/j.celrep.2024.113926","article-title":"The hippo signaling pathway in development and regeneration","volume":"43","author":"Zhong","year":"2024","journal-title":"Cell Rep."},{"key":"B126","doi-asserted-by":"publisher","first-page":"1788891","DOI":"10.1080\/19490976.2020.1788891","article-title":"Gut microbiota regulate tumor metastasis via circRNA\/miRNA networks","volume":"12","author":"Zhu","year":"2020","journal-title":"Gut Microbes"},{"key":"B127","doi-asserted-by":"publisher","first-page":"149128","DOI":"10.1016\/j.ijbiomac.2025.149128","article-title":"Pan-cancer analysis identifies adhesion G protein-coupled receptor G6 as a potential prognostic and immunotherapeutic biomarker with its functional validation","volume":"334","author":"Zhu","year":"2025","journal-title":"Int. J. Biol. Macromol."}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2026.1924197\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:36:04Z","timestamp":1790760964000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2026.1924197\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":127,"alternative-id":["10.3389\/fmolb.2026.1924197"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2026.1924197","relation":{},"ISSN":["2296-889X"],"issn-type":[{"value":"2296-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"article-number":"1924197"}}